GFAP and bipolar disorder: Taken together, our study further supports the neuroprogression hypothesis, as individuals with bipolar disorder had elevated GFAP levels, a neuroinflammatory marker, compared to healthy controls, and those with longer duration of illness exhibited higher neuroaxonal burden outpacing chronological age.